Skip to main content
Fig. 4 | Respiratory Research

Fig. 4

From: Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells

Fig. 4

a Effect of low concentrations (EC30) of glycopyrronium and indacaterol on the release of acetylcholine from intact and denuded epithelium bronchi and the influence of iberiotoxin (100 nM) and tetanus toxin (10 nM). b Effect of low concentrations (EC30) of glycopyrronium and indacaterol on the release of acetylcholine from primary bronchial epithelial cells submaximally stimulated with carbachol (EC70), and influence of quinine (100 μM). c Effect of low concentrations (EC30) of glycopyrronium and indacaterol on the histamine-induced release of acetylcholine from intact and denuded epithelium bronchi, and the influence of tetanus toxin (10 nM). d Effect of low concentrations (EC30) of glycopyrronium and indacaterol on the cAMP concentrations in intact and denuded epithelium bronchi and influence of iberiotoxin (100 nM). e Effect of low concentrations (EC30) of glycopyrronium and indacaterol on the cAMP concentrations in primary bronchial epithelial cells. Data are expressed as mean ± SEM from experiments performed using samples from n = 3 different subjects. *P < 0.05, **P < 0.01 and ***P < 0.001 vs. control (dotted line) (statistical significance assessed by t test analysis). cAMP: cyclic adenosine monophosphate; ECn: dose inducing n% maximal effect; EP+: epithelium intact; EP−: epithelium denuded; GLY: glycopyrronium bromide; IbTX: iberiotoxin; IND: indacaterol fumarate; TeTX: tetanus toxin

Back to article page